Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Margaret Geraldine Keane

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7477-4541; OpenAlex author ID A5083648826. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Editorial Note: Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation of the DNA origin activation checkpoint. Co-author DOI 10.18632/oncotarget.28902↗
  2. Early detection of pancreatic cancer. Co-author DOI 10.1016/s2468-1253(19)30416-9↗
  3. Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation of the DNA origin activation checkpoint. Co-author DOI 10.18632/oncotarget.7611↗
  4. Systematic review of novel ablative methods in locally advanced pancreatic cancer. Co-author DOI 10.3748/wjg.v20.i9.2267↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stephen P. Pereira · 3 shared papers, 2016–2026 · strength 0.47
  2. Matthew Thomas Huggett · 2 shared papers, 2016–2026 · strength 0.38
  3. Lucy S. Oldfield · 1 shared paper, 2020 · strength 0.10
  4. Alexander Ney · 1 shared paper, 2020 · strength 0.10
  5. Christie Y. Jeon · 1 shared paper, 2020 · strength 0.10
  6. Stephen Jacob Pandol · 1 shared paper, 2020 · strength 0.10
  7. William Greenhalf · 1 shared paper, 2020 · strength 0.10
  8. Eugene Jon Koay · 1 shared paper, 2020 · strength 0.10
  9. Anne Marie Lennon · 1 shared paper, 2020 · strength 0.10
  10. Debiao Li · 1 shared paper, 2020 · strength 0.10
  11. Christopher Michael Halloran · 1 shared paper, 2020 · strength 0.10
  12. Eithne Costello · 1 shared paper, 2020 · strength 0.10
  13. Phil A. Hart · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.